15 reports of this reaction
3.3% of all MANGANESE SULFATE reports
#10 most reported adverse reaction
INTENTIONAL PRODUCT USE ISSUE is the #10 most commonly reported adverse reaction for MANGANESE SULFATE, manufactured by BM Private Limited. There are 15 FDA adverse event reports linking MANGANESE SULFATE to INTENTIONAL PRODUCT USE ISSUE. This represents approximately 3.3% of all 450 adverse event reports for this drug.
Patients taking MANGANESE SULFATE who experience intentional product use issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INTENTIONAL PRODUCT USE ISSUE is moderately reported among MANGANESE SULFATE users, representing a notable but not dominant share of adverse events.
In addition to intentional product use issue, the following adverse reactions have been reported for MANGANESE SULFATE:
The following drugs have also been linked to intentional product use issue in FDA adverse event reports:
INTENTIONAL PRODUCT USE ISSUE has been reported as an adverse event in 15 FDA reports for MANGANESE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
INTENTIONAL PRODUCT USE ISSUE accounts for approximately 3.3% of all adverse event reports for MANGANESE SULFATE, making it a notable side effect.
If you experience intentional product use issue while taking MANGANESE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.